ANAPHYLAXIS
Clinical trials for ANAPHYLAXIS explained in plain language.
Never miss a new study
Get alerted when new ANAPHYLAXIS trials appear
Sign up with your email to follow new studies for ANAPHYLAXIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a simple spray replace emergency allergy shots?
Disease control Recruiting nowThis early-stage study is testing a new under-the-tongue spray (called IN-001) designed to treat severe, life-threatening allergic reactions (anaphylaxis). Researchers are comparing how the body absorbs this spray to standard epinephrine shots (like an EpiPen) in 30 healthy adult…
Matched conditions: ANAPHYLAXIS
Phase: PHASE1 • Sponsor: Insignis Therapeutics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Hunting the hidden cause of deadly surgery allergies
Diagnosis Recruiting nowThis study aims to improve how doctors diagnose and identify the specific triggers of severe allergic reactions that occur during surgery. Researchers will follow 115 patients who are suspected of having such a reaction, measuring a blood protein called tryptase and performing sk…
Matched conditions: ANAPHYLAXIS
Sponsor: Peking University First Hospital • Aim: Diagnosis
Last updated Apr 01, 2026 14:41 UTC
-
Do steroids help Kids' food allergies? new study tests emergency treatments
Symptom relief Recruiting nowThis study aims to find out if adding steroids to standard emergency medications helps children recover faster from severe food allergy reactions. During scheduled food allergy tests at clinics, 160 children with food allergies will be randomly assigned to receive either standard…
Matched conditions: ANAPHYLAXIS
Phase: PHASE4 • Sponsor: Johannes Trueck • Aim: Symptom relief
Last updated Apr 02, 2026 14:56 UTC
-
Breathing treatment tested to halt dangerous allergy attacks
Symptom relief Recruiting nowThis early-stage study is testing whether inhaling epinephrine (adrenaline) can quickly stop serious allergic reactions that happen during allergy testing or treatment. The research will involve up to 100 people aged 12 and older who experience moderate to severe reactions during…
Matched conditions: ANAPHYLAXIS
Phase: PHASE1 • Sponsor: Dr. George Luciuk • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC
-
Scientists investigate hidden clues in allergy antibodies
Knowledge-focused Recruiting nowThis study aims to understand how different versions of an allergy-related antibody (IgE) are connected to various allergic conditions. Researchers will observe 200 adult participants, including people with allergies like anaphylaxis, chronic hives, and venom allergies, as well a…
Matched conditions: ANAPHYLAXIS
Sponsor: KU Leuven • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:43 UTC